InfuSystem reports Q2 EPS 2c, consensus 0c

Reports Q2 revenue $31.7M, consensus $29.1M. Richard DiIorio, CEO of InfuSystem, said, “I am extremely pleased with the results of the second quarter, which reflect the sixth consecutive quarter with record revenues. We continue to demonstrate positive momentum against our plan by delivering solid revenue growth of 17% for the second quarter. The strength of our core businesses coupled with the execution of our long-term growth strategy in biomedical services and wound care, drove double-digit growth for both Patient Services, with revenue up 12%, and Device Solutions, with revenue up 27%. Our current progress is a direct result of our team’s hard work and commitment to providing high level service and solutions to our patients and providers.”